Next Article in Journal
Antidiabetic GLP-1 Receptor Agonists Have Neuroprotective Properties in Experimental Animal Models of Alzheimer’s Disease
Next Article in Special Issue
The Potential of Artificial Intelligence in Pharmaceutical Innovation: From Drug Discovery to Clinical Trials
Previous Article in Journal
Impact of Co-Occurring Psychiatric Comorbidities and Substance Use Disorders on Outcomes in Adolescents and Young Adults with Opioid Use Disorder: A Retrospective Cohort Study
Previous Article in Special Issue
Design, Synthesis, and Computational Evaluation of 3,4-Dihydroquinolin-2(1H)-One Analogues as Potential VEGFR2 Inhibitors in Glioblastoma Multiforme
 
 
Article

Article Versions Notes

Pharmaceuticals 2025, 18(5), 613; https://doi.org/10.3390/ph18050613
Action Date Notes Link
article pdf uploaded. 23 April 2025 14:35 CEST Version of Record https://www.mdpi.com/1424-8247/18/5/613/pdf-vor
article supplementary file uploaded. 23 April 2025 14:35 CEST - https://www.mdpi.com/1424-8247/18/5/613#supplementary
article pdf uploaded. 23 April 2025 16:12 CEST Updated version of record https://www.mdpi.com/1424-8247/18/5/613/pdf-vor
article xml file uploaded 24 April 2025 11:59 CEST Original file -
article xml uploaded. 24 April 2025 11:59 CEST Update -
article pdf uploaded. 24 April 2025 11:59 CEST Updated version of record https://www.mdpi.com/1424-8247/18/5/613/pdf-vor
article html file updated 24 April 2025 12:01 CEST Original file -
article html file updated 30 April 2025 05:14 CEST Update https://www.mdpi.com/1424-8247/18/5/613/html
article xml file uploaded 30 April 2025 05:15 CEST Update -
article xml uploaded. 30 April 2025 05:15 CEST Update https://www.mdpi.com/1424-8247/18/5/613/xml
article pdf uploaded. 30 April 2025 05:15 CEST Updated version of record https://www.mdpi.com/1424-8247/18/5/613/pdf
Back to TopTop